Epidemiological, clinical, and genomic landscape of coccidioidomycosis in northeastern Brazil.
Kelsen Dantas EulálioDaniel R KollathLiline Maria Soares MartinsAntonio de Deus FilhoMaria do Amparo Salmito CavalcantiLucas Machado MoreiraBernardo Guerra TenórioLucas Gomes de Brito AlvesDanielle YamauchiLigia Vizeu BarrozoGeorge R Thompson IiiMathieu NacherJason E StajichGil BenardEduardo BagagliMaria Sueli Soares FelipeBridget Marie BarkerLuciana TrillesMarcus de Melo TeixeiraPublished in: Nature communications (2024)
Coccidioidomycosis, listed as a priority mycosis by the WHO, is endemic in the United States but often overlooked in Central and South America. Employing a multi-institutional approach, we investigate how disease characteristics, pathogen genetic variation, and environmental factors impact coccidioidomycosis epidemiology and outcomes in South America. We identified 292 cases (1978-2021) and 42 outbreaks in Piauí and Maranhão states, Brazil, the largest series outside the US/Mexico epidemic zone. The male-to-female ratio was 57.4:1 and the most common activity was armadillo hunting (91.1%) 4 to 30 days before symptom onset. Most patients (92.8%) exhibited typical acute pulmonary disease, with cough (93%), fever (90%), and chest pain (77%) as predominant symptoms. The case fatality rate was 8%. Our negative binomial regression model indicates that reduced precipitation levels in the current (p = 0.015) and preceding year (p = 0.001) predict heightened incidence. Unlike other hotspots, acidic soil characterizes this region. Brazilian strains differ genomically from other C. posadasii lineages. Northeastern Brazil presents a distinctive coccidioidomycosis profile, with armadillo hunters facing elevated risks. Low annual rainfall emerges as a key factor in increasing cases. A unique C. posadasii lineage in Brazil suggests potential differences in environmental, virulence, and/or pathogenesis traits compared to other Coccidioides genotypes.
Keyphrases
- escherichia coli
- end stage renal disease
- human health
- risk factors
- ejection fraction
- newly diagnosed
- chronic kidney disease
- type diabetes
- liver failure
- prognostic factors
- staphylococcus aureus
- adipose tissue
- peritoneal dialysis
- antimicrobial resistance
- cystic fibrosis
- respiratory failure
- metabolic syndrome
- patient reported
- copy number
- drug induced
- patient reported outcomes
- sleep quality
- aortic dissection
- cell fate
- extracorporeal membrane oxygenation